Mechanisms and strategies of immunosenescence effects on non-small cell lung cancer (NSCLC) treatment: A comprehensive analysis and future directions.

The review highlights emerging technologies, such as single-cell sequencing and CRISPR-Cas9, which offer new insights into immunosenescence and its potential as a therapeutic target and outlines future research directions, including strategies for rejuvenating the aging immune system and optimizing immunotherapy for older NSCLC patients.